首页 > 最新文献

Journal of Stroke & Cerebrovascular Diseases最新文献

英文 中文
Aspirin-ticagrelor use after mild acute ischemic stroke: Findings from the get with the guidelines-stroke registry 轻度急性缺血性卒中后阿司匹林-替格瑞洛的使用:来自卒中登记指南的发现
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2026-01-19 DOI: 10.1016/j.jstrokecerebrovasdis.2026.108564
Ava L. Liberman MD , Cenai Zhang BS , Sara K. Rostanski MD , Hooman Kamel MD MS , Babak B. Navi MD MS , Natalie T. Cheng MD , Radhika Sundararajan MD PhD , Steven R. Messe MD , Gregg C. Fonarow MD , Shyam Prabhakaran MD MS , Ying Xian MD PhD

Background

Recent guidelines suggest that aspirin-ticagrelor may be considered for stroke prevention after mild acute ischemic stroke. However, it is unclear how commonly this dual antiplatelet therapy (DAPT) regimen is used in practice.

Methods

We performed a cross-sectional analysis of the Get With The Guidelines-Stroke registry 2017-2023. Patients with a non-cardioembolic mild ischemic stroke (defined as NIHSS <6) who presented within 24 hours of last known well without a contraindication to DAPT were included. The primary study outcome was the proportion of patients prescribed aspirin-ticagrelor at hospital discharge; temporal patterns of prescribing aspirin-ticagrelor and aspirin-clopidogrel over time are also described. In addition to standard tests of comparison, we used multiple logistic regression to evaluate associations between patient and facility factors and aspirin-ticagrelor use reported as odds ratios (OR) with 95% confidence intervals (CI).

Results

Among 1,018,736 patients meeting study criteria, 478,049 (46.9%) were female and median age was 68 (IQR: 59, 78) years. A total of 12,845 (1.3%) patients were discharged on aspirin-ticagrelor whereas 448,348 (44.0%) were discharged on aspirin-clopidogrel. Prescriptions for aspirin-ticagrelor and for aspirin-clopidogrel significantly increased over the study time-period. In regression analysis, coronary artery disease/prior myocardial infarction (OR: 2.6 [95% CI: 2.5-2.7]), Asian race (OR: 2.1 [95% CI: 1.9-2.2]), aspirin-clopidogrel prescription upon admission (OR: 2.0 [95% CI:1.9-2.1]), and history of stroke/TIA (OR: 1.98 [95% CI: (1.9-2.1)]), were substantially associated with aspirin-ticagrelor use whereas lacking insurance/self-pay (OR: 0.7 [95% CI: 0.6-0.8]), rural setting (OR: 0.8 [95% 0.7-0.9]), and primary stroke centers (OR: 0.3 [95% CI: 0.3-0.4]) were inversely associated with aspirin-ticagrelor. In the subgroup of 176,897 (17.4%) patients with NIHSS 4-5, 74,912 (50.8%) were discharged on aspirin-clopidogrel and 2,394 (1.4%) on aspirin-ticagrelor.

Conclusion

Unlike aspirin-clopidogrel, aspirin-ticagrelor is infrequently administered after mild acute ischemic stroke (NIHSS <6) despite current guidelines, though the use of both DAPT regimens increased over time.
背景:最近的指南建议阿司匹林-替格瑞洛可用于轻度急性缺血性卒中后的卒中预防。然而,目前尚不清楚这种双重抗血小板治疗(DAPT)方案在实践中的应用有多普遍。方法:我们对2017-2023年Get With the Guidelines-Stroke注册表进行了横断面分析。结果:1018736例符合研究标准的患者中,478049例(46.9%)为女性,中位年龄为68岁(IQR: 59,78)。共有12845例(1.3%)患者使用阿斯匹林-替格瑞洛出院,而448348例(44.0%)患者使用阿斯匹林-氯吡格雷出院。阿斯匹林-替格瑞洛和阿斯匹林-氯吡格雷的处方在研究期间显著增加。在回归分析中,冠状动脉疾病/既往心肌梗死(OR: 2.6 [95% CI: 2.5-2.7])、亚洲种族(OR: 2.1 [95% CI: 1.9-2.2])、入院时阿司匹林-氯吡格雷处方(OR: 2.0 [95% CI:1.9-2.1])、卒中史/TIA (OR: 1.98 [95% CI:1.9-2.1))与阿司匹林-替格瑞洛的使用存在显著相关性,而缺乏保险/自费(OR: 0.7 [95% CI: 0.6-0.8])、农村环境(OR: 0.8 [95% CI: 0.7-0.9])和主要卒中中心(OR: 0.3 [95% CI: 0.9])与阿司匹林-替格瑞洛的使用存在显著相关性。0.3-0.4])与阿斯匹林-替格瑞洛呈负相关。在176,897例(17.4%)NIHSS 4-5患者亚组中,74,912例(50.8%)患者出院时使用阿司匹林-氯吡格雷,2,394例(1.4%)患者出院时使用阿司匹林-替格瑞洛。结论:与阿斯匹林-氯吡格雷不同,阿斯匹林-替格瑞洛在轻度急性缺血性卒中(NIHSS)后很少使用
{"title":"Aspirin-ticagrelor use after mild acute ischemic stroke: Findings from the get with the guidelines-stroke registry","authors":"Ava L. Liberman MD ,&nbsp;Cenai Zhang BS ,&nbsp;Sara K. Rostanski MD ,&nbsp;Hooman Kamel MD MS ,&nbsp;Babak B. Navi MD MS ,&nbsp;Natalie T. Cheng MD ,&nbsp;Radhika Sundararajan MD PhD ,&nbsp;Steven R. Messe MD ,&nbsp;Gregg C. Fonarow MD ,&nbsp;Shyam Prabhakaran MD MS ,&nbsp;Ying Xian MD PhD","doi":"10.1016/j.jstrokecerebrovasdis.2026.108564","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2026.108564","url":null,"abstract":"<div><h3>Background</h3><div>Recent guidelines suggest that aspirin-ticagrelor may be considered for stroke prevention after mild acute ischemic stroke. However, it is unclear how commonly this dual antiplatelet therapy (DAPT) regimen is used in practice.</div></div><div><h3>Methods</h3><div>We performed a cross-sectional analysis of the Get With The Guidelines-Stroke registry 2017-2023. Patients with a non-cardioembolic mild ischemic stroke (defined as NIHSS &lt;6) who presented within 24 hours of last known well without a contraindication to DAPT were included. The primary study outcome was the proportion of patients prescribed aspirin-ticagrelor at hospital discharge; temporal patterns of prescribing aspirin-ticagrelor and aspirin-clopidogrel over time are also described. In addition to standard tests of comparison, we used multiple logistic regression to evaluate associations between patient and facility factors and aspirin-ticagrelor use reported as odds ratios (OR) with 95% confidence intervals (CI).</div></div><div><h3>Results</h3><div>Among 1,018,736 patients meeting study criteria, 478,049 (46.9%) were female and median age was 68 (IQR: 59, 78) years. A total of 12,845 (1.3%) patients were discharged on aspirin-ticagrelor whereas 448,348 (44.0%) were discharged on aspirin-clopidogrel. Prescriptions for aspirin-ticagrelor and for aspirin-clopidogrel significantly increased over the study time-period. In regression analysis, coronary artery disease/prior myocardial infarction (OR: 2.6 [95% CI: 2.5-2.7]), Asian race (OR: 2.1 [95% CI: 1.9-2.2]), aspirin-clopidogrel prescription upon admission (OR: 2.0 [95% CI:1.9-2.1]), and history of stroke/TIA (OR: 1.98 [95% CI: (1.9-2.1)]), were substantially associated with aspirin-ticagrelor use whereas lacking insurance/self-pay (OR: 0.7 [95% CI: 0.6-0.8]), rural setting (OR: 0.8 [95% 0.7-0.9]), and primary stroke centers (OR: 0.3 [95% CI: 0.3-0.4]) were inversely associated with aspirin-ticagrelor. In the subgroup of 176,897 (17.4%) patients with NIHSS 4-5, 74,912 (50.8%) were discharged on aspirin-clopidogrel and 2,394 (1.4%) on aspirin-ticagrelor.</div></div><div><h3>Conclusion</h3><div>Unlike aspirin-clopidogrel, aspirin-ticagrelor is infrequently administered after mild acute ischemic stroke (NIHSS &lt;6) despite current guidelines, though the use of both DAPT regimens increased over time.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 3","pages":"Article 108564"},"PeriodicalIF":1.8,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146021149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective association of higher frequency physical exercise with all-cause mortality risk in stroke patients: evidence from the health and retirement study 高频率体育锻炼与卒中患者全因死亡风险的保护性关联:来自健康与退休研究的证据
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2026-01-18 DOI: 10.1016/j.jstrokecerebrovasdis.2026.108563
Jingtao Du , Xiaofeng Jiang , Binghua Shao , Liu Zhenshun , Liu Tianyu , Jianwei Wu

Objective

To examine the association between the different exercise frequency in daily life and all-cause mortality risk of the patients after stroke, and to analyze their dose-response relationship.

Methods

1,639 participants with stroke were selected from Health and Retirement Study (HRS) database. Based on physical exercise frequency questionnaires, participants were categorized into five groups: sedentary (n=152), low (n=276), moderate (n=212), high (n=205), and vigorous (n=794). Multivariate Cox proportional hazards regression models and survival analyses were applied to examine the associations between exercise frequency and all-cause mortality risk in stroke patients.

Results

Median follow-up time revealed that both median survival time and interquartile range increased progressively with higher exercise frequency. Multivariate Cox regression analysis demonstrated a significant dose-response relationship: Compared to the sedentary group, moderate, high, and vigorous exercise groups exhibited significantly reduced death risks of 28%, 35%, and 42%, respectively. Exercise score showed a significant negative correlation with mortality rate (r=-0.855). Kaplan-Meier survival analysis revealed significant divergence in survival curves among different exercise frequency groups (log-rank P<0.001), with the vigorous exercise group demonstrating the highest cumulative survival rate. Age-stratified analysis indicated that patients aged ≤65 years had the most favorable survival prognosis, while survival rates significantly decreased with advancing age (log-rank P< 0.001).

Conclusion

Higher frequency physical exercise manifested a protective association with reduced all-cause mortality risk in stroke patients, with a clear dose-response relationship. These findings support incorporating regular moderate-to-high-frequency exercise into daily life to reduce the hazards of stroke and improve long-term prognosis.
目的:探讨日常生活中不同运动频率与脑卒中患者全因死亡风险的关系,并分析两者的量效关系。方法:从健康与退休研究(HRS)数据库中选取1639例脑卒中患者。根据体育锻炼频率问卷,参与者被分为五组:久坐(n=152),低(n=276),中等(n=212),高(n=205)和剧烈(n=794)。应用多变量Cox比例风险回归模型和生存分析来检验卒中患者运动频率与全因死亡风险之间的关系。结果:中位随访时间显示,随着运动频率的增加,中位生存时间和四分位间距逐渐增加。多变量Cox回归分析显示了显著的剂量-反应关系:与久坐组相比,中度、高强度和剧烈运动组的死亡风险分别显著降低了28%、35%和42%。运动评分与死亡率呈显著负相关(r=-0.855)。Kaplan-Meier生存分析显示,不同运动频率组的生存曲线存在显著差异(log-rank P < 0.001),剧烈运动组的累积生存率最高。年龄分层分析显示,年龄≤65岁的患者生存预后最有利,随着年龄的增长,生存率显著降低(log-rank P < 0.001)。结论:高频率的体育锻炼与降低脑卒中患者全因死亡风险具有保护作用,且存在明显的剂量-反应关系。这些发现支持在日常生活中加入定期的中高频率运动,以减少中风的危险,改善长期预后。
{"title":"Protective association of higher frequency physical exercise with all-cause mortality risk in stroke patients: evidence from the health and retirement study","authors":"Jingtao Du ,&nbsp;Xiaofeng Jiang ,&nbsp;Binghua Shao ,&nbsp;Liu Zhenshun ,&nbsp;Liu Tianyu ,&nbsp;Jianwei Wu","doi":"10.1016/j.jstrokecerebrovasdis.2026.108563","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2026.108563","url":null,"abstract":"<div><h3>Objective</h3><div>To examine the association between the different exercise frequency in daily life and all-cause mortality risk of the patients after stroke, and to analyze their dose-response relationship.</div></div><div><h3>Methods</h3><div>1,639 participants with stroke were selected from Health and Retirement Study (HRS) database. Based on physical exercise frequency questionnaires, participants were categorized into five groups: sedentary (n=152), low (n=276), moderate (n=212), high (n=205), and vigorous (n=794). Multivariate Cox proportional hazards regression models and survival analyses were applied to examine the associations between exercise frequency and all-cause mortality risk in stroke patients.</div></div><div><h3>Results</h3><div>Median follow-up time revealed that both median survival time and interquartile range increased progressively with higher exercise frequency. Multivariate Cox regression analysis demonstrated a significant dose-response relationship: Compared to the sedentary group, moderate, high, and vigorous exercise groups exhibited significantly reduced death risks of 28%, 35%, and 42%, respectively. Exercise score showed a significant negative correlation with mortality rate (r=-0.855). Kaplan-Meier survival analysis revealed significant divergence in survival curves among different exercise frequency groups (log-rank P&lt;0.001), with the vigorous exercise group demonstrating the highest cumulative survival rate. Age-stratified analysis indicated that patients aged ≤65 years had the most favorable survival prognosis, while survival rates significantly decreased with advancing age (log-rank P&lt; 0.001).</div></div><div><h3>Conclusion</h3><div>Higher frequency physical exercise manifested a protective association with reduced all-cause mortality risk in stroke patients, with a clear dose-response relationship. These findings support incorporating regular moderate-to-high-frequency exercise into daily life to reduce the hazards of stroke and improve long-term prognosis.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 3","pages":"Article 108563"},"PeriodicalIF":1.8,"publicationDate":"2026-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146014206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcatheter closure versus antithrombotic therapy for cryptogenic stroke in elderly patients with patent foramen ovale: a systematic review and meta-analysis of non-randomized studies 经导管闭合与抗血栓治疗治疗老年卵圆孔未闭患者隐源性卒中:一项非随机研究的系统回顾和荟萃分析
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2026-01-16 DOI: 10.1016/j.jstrokecerebrovasdis.2026.108562
Yang Dong MD , Cong Lu MD , Tiantian Luo PhD , Hao Huang MD , Yan Xiong MD , Jie Zeng MD

Background

There is lacking of robust clinical evidence comparing transcatheter closure with antithrombotic therapy in elderly patent foramen ovale (PFO) patients with cryptogenic stroke.

Methods

The Pubmed, Embase, Web of Science, clinicaltrials.gov and Cochrane Library databases were systematically searched. Studies comparing transcatheter closure therapy with antithrombotic drug therapy in PFO patients in older age (≥55 years old) were included. The number of patients with and without events in both experimental group and control group were extracted. There were three study endpoints: composite endpoint of recurrent ischemic stroke and transient ischemic attack (TIA); all-cause death; new-onset atrial fibrillation. A random-effect model was performed. Heterogeneity among selected publications was assessed using Q-test based on a χ² test. I2>50% was defined as high heterogeneity. P < 0.05 was considered statistically significant.

Results

Nine studies of 7275 elderly PFO patients with cryptogenic stroke were included. Patients undergoing PFO closure had significantly lower risk of a composite endpoint of recurrent stroke and TIA (4.74% versus 8.08%, OR=0.517, 95% CI:0.325-0.821) and all-cause death (1.17% versus 1.24%, OR=0.531, 95% CI: 0.317-0.891). There was no significant different occurrence of new-onset atrial fibrillation between the two groups (3.81% versus 2.82%, OR=1.218, 95% CI: 0.826-1.798). None of the studies measuring the three endpoints manifested high heterogeneity.

Conclusions

PFO closure might reduce the risk of composite endpoint of recurrent stroke and TIA and all-cause death, while not increase the risk of new-onset atrial fibrillation comparing with medication therapy in elderly PFO patients with cryptogenic stroke. PFO closure should be considered part of a comprehensive secondary prevention strategy in elderly patients.
背景:对于老年隐源性脑卒中卵圆孔未闭(PFO)患者,比较经导管闭合与抗血栓治疗缺乏强有力的临床证据。方法:系统检索Pubmed、Embase、Web of Science、clinicaltrials.gov和Cochrane Library数据库。比较高龄PFO患者(≥55岁)经导管闭合治疗与抗血栓药物治疗的研究。提取实验组和对照组发生和未发生事件的患者数量。研究有三个终点:复发性脑卒中和短暂性脑缺血发作(TIA)的复合终点;全因死亡;新发心房颤动。采用随机效应模型。采用基于χ 2检验的q检验评估所选出版物的异质性。I2>50%定义为高异质性。P < 0.05为差异有统计学意义。结果:9项研究纳入7275例老年PFO伴隐源性卒中患者。接受PFO闭合的患者卒中和TIA复发的复合终点(4.74%对8.08%,OR=0.517, 95% CI: 0.25 -0.821)和全因死亡(1.17%对1.24%,OR=0.531, 95% CI: 0.317-0.891)的风险显著降低。两组间新发房颤发生率无显著差异(3.81% vs 2.82%, OR=1.218, 95% CI: 0.826-1.798)。测量这三个终点的研究均未显示出高度异质性。结论:与药物治疗相比,PFO关闭可降低老年PFO隐源性卒中合并TIA复合终点复发风险和全因死亡风险,但不会增加新发房颤的风险。PFO闭合应被视为老年患者综合二级预防策略的一部分。
{"title":"Transcatheter closure versus antithrombotic therapy for cryptogenic stroke in elderly patients with patent foramen ovale: a systematic review and meta-analysis of non-randomized studies","authors":"Yang Dong MD ,&nbsp;Cong Lu MD ,&nbsp;Tiantian Luo PhD ,&nbsp;Hao Huang MD ,&nbsp;Yan Xiong MD ,&nbsp;Jie Zeng MD","doi":"10.1016/j.jstrokecerebrovasdis.2026.108562","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2026.108562","url":null,"abstract":"<div><h3>Background</h3><div>There is lacking of robust clinical evidence comparing transcatheter closure with antithrombotic therapy in elderly patent foramen ovale (PFO) patients with cryptogenic stroke.</div></div><div><h3>Methods</h3><div>The Pubmed, Embase, Web of Science, clinicaltrials.gov and Cochrane Library databases were systematically searched. Studies comparing transcatheter closure therapy with antithrombotic drug therapy in PFO patients in older age (≥55 years old) were included. The number of patients with and without events in both experimental group and control group were extracted. There were three study endpoints: composite endpoint of recurrent ischemic stroke and transient ischemic attack (TIA); all-cause death; new-onset atrial fibrillation. A random-effect model was performed. Heterogeneity among selected publications was assessed using Q-test based on a χ² test. I<sup>2</sup>&gt;50% was defined as high heterogeneity. P &lt; 0.05 was considered statistically significant.</div></div><div><h3>Results</h3><div>Nine studies of 7275 elderly PFO patients with cryptogenic stroke were included. Patients undergoing PFO closure had significantly lower risk of a composite endpoint of recurrent stroke and TIA (4.74% versus 8.08%, OR=0.517, 95% CI:0.325-0.821) and all-cause death (1.17% versus 1.24%, OR=0.531, 95% CI: 0.317-0.891). There was no significant different occurrence of new-onset atrial fibrillation between the two groups (3.81% versus 2.82%, OR=1.218, 95% CI: 0.826-1.798). None of the studies measuring the three endpoints manifested high heterogeneity.</div></div><div><h3>Conclusions</h3><div>PFO closure might reduce the risk of composite endpoint of recurrent stroke and TIA and all-cause death, while not increase the risk of new-onset atrial fibrillation comparing with medication therapy in elderly PFO patients with cryptogenic stroke. PFO closure should be considered part of a comprehensive secondary prevention strategy in elderly patients.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 3","pages":"Article 108562"},"PeriodicalIF":1.8,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145994757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapid enlargement of a pre-existing intracranial aneurysm during infective endocarditis: a case report 感染性心内膜炎时原有颅内动脉瘤迅速增大1例。
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2026-01-15 DOI: 10.1016/j.jstrokecerebrovasdis.2026.108561
Mamoru Ishida MD, PhD, Ryosuke Nishiwaki MD, Hisashi Mizutani MD, Yuichi Kawasaki MD, Takahiro Oyama MD, Mitsuhiro Yoshida MD

Background

Infectious intracranial aneurysms (IIAs) are generally thought to develop de novo as a consequence of septic embolization during infective endocarditis (IE). Rapid infection-related enlargement of a pre-existing unruptured aneurysm during IE has not been previously documented. We report a case in which a small middle cerebral artery (MCA) aneurysm, previously identified on imaging, enlarged rapidly in the course of IE.

Case Description

A 67-year-old woman with a history of mitral valve repair presented with progressive general malaise and mild left hemiparesis. MRI demonstrated acute infarctions in the right caudate nucleus and putamen, and MRA showed occlusion of the right M2 superior branch. A previously identified 2.2-mm right MCA bifurcation aneurysm was not visualized on admission MRA. Infective endocarditis was subsequently diagnosed, and the aneurysm reappeared on day 9 at 5.5 mm and enlarged further to 9.5 mm by day 15. Endovascular coil embolization was performed on day 16, achieving complete aneurysm occlusion. The patient later underwent mitral valve surgery without complications.

Conclusion

This case demonstrates infection-related enlargement of a pre-existing intracranial aneurysm during IE, documented chronologically with serial MRA. These findings highlight the need for careful interval imaging in patients with IE and known aneurysms, and rapid morphological change should prompt urgent aneurysm treatment.
背景:感染性颅内动脉瘤(IIAs)通常被认为是感染性心内膜炎(IE)期间脓毒性栓塞的结果。IE期间存在的未破裂动脉瘤的快速感染相关扩大以前没有文献记载。我们报告一个病例,其中一个小的大脑中动脉(MCA)动脉瘤,先前在影像学上发现,在IE过程中迅速扩大。病例描述:一名67岁女性,有二尖瓣修复史,表现为进行性全身不适和轻度左偏瘫。MRI显示右侧尾状核和壳核急性梗死,MRA显示右侧M2上支闭塞。先前确定的2.2 mm右MCA分叉动脉瘤在入院MRA上未见。随后诊断为感染性心内膜炎,第9天动脉瘤再次出现,直径5.5 mm,第15天进一步扩大至9.5 mm。第16天行血管内线圈栓塞术,实现动脉瘤完全闭塞。患者后来接受了二尖瓣手术,无并发症。结论:该病例显示IE期间已有的颅内动脉瘤感染相关肿大,按时间顺序通过系列MRA记录。这些发现强调了IE和已知动脉瘤患者需要仔细的间隔成像,快速的形态学改变应该促使动脉瘤紧急治疗。
{"title":"Rapid enlargement of a pre-existing intracranial aneurysm during infective endocarditis: a case report","authors":"Mamoru Ishida MD, PhD,&nbsp;Ryosuke Nishiwaki MD,&nbsp;Hisashi Mizutani MD,&nbsp;Yuichi Kawasaki MD,&nbsp;Takahiro Oyama MD,&nbsp;Mitsuhiro Yoshida MD","doi":"10.1016/j.jstrokecerebrovasdis.2026.108561","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2026.108561","url":null,"abstract":"<div><h3>Background</h3><div>Infectious intracranial aneurysms (IIAs) are generally thought to develop de novo as a consequence of septic embolization during infective endocarditis (IE). Rapid infection-related enlargement of a pre-existing unruptured aneurysm during IE has not been previously documented. We report a case in which a small middle cerebral artery (MCA) aneurysm, previously identified on imaging, enlarged rapidly in the course of IE.</div></div><div><h3>Case Description</h3><div>A 67-year-old woman with a history of mitral valve repair presented with progressive general malaise and mild left hemiparesis. MRI demonstrated acute infarctions in the right caudate nucleus and putamen, and MRA showed occlusion of the right M2 superior branch. A previously identified 2.2-mm right MCA bifurcation aneurysm was not visualized on admission MRA. Infective endocarditis was subsequently diagnosed, and the aneurysm reappeared on day 9 at 5.5 mm and enlarged further to 9.5 mm by day 15. Endovascular coil embolization was performed on day 16, achieving complete aneurysm occlusion. The patient later underwent mitral valve surgery without complications.</div></div><div><h3>Conclusion</h3><div>This case demonstrates infection-related enlargement of a pre-existing intracranial aneurysm during IE, documented chronologically with serial MRA. These findings highlight the need for careful interval imaging in patients with IE and known aneurysms, and rapid morphological change should prompt urgent aneurysm treatment.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 3","pages":"Article 108561"},"PeriodicalIF":1.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145994753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longitudinal comparison of health-related quality of life at 3 and 12 months post-stroke using patient-reported outcome measures 卒中后3个月和12个月健康相关生活质量的纵向比较
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2026-01-14 DOI: 10.1016/j.jstrokecerebrovasdis.2026.108559
Hojin Ju MD , Won Kee Chang MD, MS , Hee-Mun Cho MD , Hyo Jong Kim MD , Miji Kang RN , Yun-Sun Jung MPH, PhD , Nam-Jong Paik MD, PhD , Won-Seok Kim MD, PhD

Background

Health-related quality of life (HRQoL) is a key outcome in stroke survivors, but evidence on distinct physical and mental recovery trajectories is limited. EuroQoL 5-dimension 3-level (EQ-5D-3L) is widely used but prone to ceiling effects and cannot separate physical (PH) and mental health (MH). We administered Patient-Reported Outcomes Measurement Information System 10-item short form (PROMIS-10) at 3 and 12 months post-stroke, identified discharge-related predictors of PROMIS-10 PH and MH to distinguish their recovery trajectories, and compared their discriminatory capacity with that of EQ-5D-3L.

Methods

We analyzed PROMIS-10 and EQ-5D-3L scores in a retrospective cohort of 741 stroke survivors discharged from a tertiary center and followed at 3 and 12 months. Discriminatory capacity across modified Rankin Scale (mRS) groups was assessed using effect sizes. Linear regression identified demographic and clinical predictors of PROMIS-10 PH and MH at 3 and 12 months.

Results

At 3 months, EQ-5D-3L demonstrated greater discriminatory capacity across mRS groups. At 12 months, PH exhibited better discriminatory capacity than EQ-5D-3L for mild disability (mRS 0–1 vs. 2), consistent with ceiling effects reducing EQ-5D-3L sensitivity in the mild impairment group. Discharge ambulation consistently predicted both PH and MH at 3 and 12 months. Comorbidity burden, employment status, respondent type (proxy vs. patient), and discharge destination were associated with PROMIS-10, particularly in 12-month MH.

Conclusion

Predictors and trajectories differed between PH and MH groups, supporting separate assessment. PROMIS-10 exhibited better discriminatory capacity of milder disability at 12 months by distinguishing physical and mental dimensions, supporting tailored care basis.
背景:与健康相关的生活质量(HRQoL)是脑卒中幸存者的一个关键结果,但关于明显的身体和精神恢复轨迹的证据有限。EuroQoL 5维3级(EQ-5D-3L)被广泛使用,但容易产生天花板效应,不能将身体(PH)和精神健康(MH)分开。我们在脑卒中后3个月和12个月使用了患者报告结果测量信息系统10项短表(promise -10),确定了与出院相关的promise -10 PH和MH预测因子,以区分其恢复轨迹,并将其与EQ-5D-3L的区分能力进行了比较。方法:我们分析了741名从三级中心出院的中风幸存者的promise -10和EQ-5D-3L评分,并在3个月和12个月进行了随访。采用效应量评估改良兰金量表(mRS)组的歧视能力。线性回归确定了3个月和12个月时promise -10 PH和MH的人口学和临床预测因子。结果:在3个月时,EQ-5D-3L在mRS组中表现出更大的歧视能力。在12个月时,PH对轻度残疾表现出比EQ-5D-3L更好的区分能力(mRS 0-1 vs. 2),这与天花板效应降低轻度损伤组EQ-5D-3L的敏感性一致。出院活动与3个月和12个月时PH和MH的预测一致。共病负担、就业状况、被调查者类型(代理与患者)和出院目的地与promise -10相关,特别是在12个月的MH中。结论:PH组和MH组之间的预测因子和轨迹存在差异,支持单独评估。通过区分身体和心理维度,promise -10在12个月时对轻度残疾表现出更好的区分能力,支持量身定制的护理基础。
{"title":"Longitudinal comparison of health-related quality of life at 3 and 12 months post-stroke using patient-reported outcome measures","authors":"Hojin Ju MD ,&nbsp;Won Kee Chang MD, MS ,&nbsp;Hee-Mun Cho MD ,&nbsp;Hyo Jong Kim MD ,&nbsp;Miji Kang RN ,&nbsp;Yun-Sun Jung MPH, PhD ,&nbsp;Nam-Jong Paik MD, PhD ,&nbsp;Won-Seok Kim MD, PhD","doi":"10.1016/j.jstrokecerebrovasdis.2026.108559","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2026.108559","url":null,"abstract":"<div><h3>Background</h3><div>Health-related quality of life (HRQoL) is a key outcome in stroke survivors, but evidence on distinct physical and mental recovery trajectories is limited. EuroQoL 5-dimension 3-level (EQ-5D-3L) is widely used but prone to ceiling effects and cannot separate physical (PH) and mental health (MH). We administered Patient-Reported Outcomes Measurement Information System 10-item short form (PROMIS-10) at 3 and 12 months post-stroke, identified discharge-related predictors of PROMIS-10 PH and MH to distinguish their recovery trajectories, and compared their discriminatory capacity with that of EQ-5D-3L.</div></div><div><h3>Methods</h3><div>We analyzed PROMIS-10 and EQ-5D-3L scores in a retrospective cohort of 741 stroke survivors discharged from a tertiary center and followed at 3 and 12 months. Discriminatory capacity across modified Rankin Scale (mRS) groups was assessed using effect sizes. Linear regression identified demographic and clinical predictors of PROMIS-10 PH and MH at 3 and 12 months.</div></div><div><h3>Results</h3><div>At 3 months, EQ-5D-3L demonstrated greater discriminatory capacity across mRS groups. At 12 months, PH exhibited better discriminatory capacity than EQ-5D-3L for mild disability (mRS 0–1 vs. 2), consistent with ceiling effects reducing EQ-5D-3L sensitivity in the mild impairment group. Discharge ambulation consistently predicted both PH and MH at 3 and 12 months. Comorbidity burden, employment status, respondent type (proxy vs. patient), and discharge destination were associated with PROMIS-10, particularly in 12-month MH.</div></div><div><h3>Conclusion</h3><div>Predictors and trajectories differed between PH and MH groups, supporting separate assessment. PROMIS-10 exhibited better discriminatory capacity of milder disability at 12 months by distinguishing physical and mental dimensions, supporting tailored care basis.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 3","pages":"Article 108559"},"PeriodicalIF":1.8,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145992941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RKIP regulates the ERK/MAPK signaling pathway to improve neuroinflammatory injury in male rats with ischemic stroke RKIP通过调控ERK/MAPK信号通路改善雄性缺血性脑卒中大鼠的神经炎症损伤。
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2026-01-14 DOI: 10.1016/j.jstrokecerebrovasdis.2026.108560
Rui Mao, Xin Tan, Rong Li, Zhiyong Yang, Hua Liu

Background

To explore the mechanism by which RAF kinase inhibitory protein (RKIP) alleviates neuroinflammatory damage in male rats with ischemic stroke (IS).

Methods

Male rats were subjected to middle cerebral artery occlusion (MCAO) to establish an IS model. Two weeks before MCAO, a single tail-vein injection of lentivirus or an equivalent volume of normal saline was administered to rats. The neurological deficit scores, infarct volume fractions, and pathological changes of the ischemic penumbra were evaluated in the rats. Immunohistochemstry, double-labeled immunofluorescence, ELISA, and Western blot were performed to assess microglial polarization, neuroinflammation and ERK/MAPK-related protein expressions.

Results

IS rats exhibited elevated neurological deficit scores and enlarged infarct volume fractions, accompanied by aggravated histopathological damage in the ischemic penumbra. Microglial M1 polarization was enhanced, meanwhile, IL-6 and TNF-α were up-regulated, whereas the anti-inflammatory mediator IL-10 was down-regulated, indicating a pronounced neuroinflammatory response. In particular, Western blot results showed that the ischemic penumbra expression of RKIP in IS rats was markedly lower in IS group than that in Control group. After achieving RKIP overexpression via lentivirus mediation, the polarization direction of microglia in the ischemic penumbra of IS rats shifted toward the M2 phenotype. This was specifically manifested by a significant decrease in the proportion of iNOS⁺/Iba1⁺ double-positive microglia, while the proportion of Arg-1⁺/Iba1⁺ double-positive microglia was significantly increased, and the neuroinflammatory response was alleviated. Moreover, its overexpression significantly reduced the expressions of p-ERK1/2 and p-p38 MAPK in ischemic penumbra. Interestingly, rmEGF-activated ERK elevated the protein levels of p-ERK1/2 and p-p38 MAPK in ischemic penumbra without altering RKIP expression itself. Consequently, the proportion of iNOS⁺/Iba1⁺ double-positive microglia rebounded, while that of Arg-1⁺/Iba1⁺ double-positive microglia decreased . Finally, functional experiments demonstrated that ERK partially reversed the neuroinflammatory protection conferred by RKIP overexpression in IS rats.

Conclusion

Overexpression of RKIP may alleviate the neuroinflammatory damage in IS rats by inhibiting ERK/MAPK pathway, thereby improving neurological function.
背景:探讨RAF激酶抑制蛋白(RKIP)减轻雄性缺血性脑卒中大鼠神经炎症损伤的机制。方法:雄性大鼠大脑中动脉闭塞(MCAO)建立缺血性脑卒中(IS)模型。在MCAO前2周,给予大鼠尾静脉单次注射慢病毒或等量生理盐水。测定大鼠神经功能缺损评分、梗死体积分数及缺血半暗带病理改变。采用免疫组织化学、双标记免疫荧光、ELISA和Western blot检测小胶质细胞极化、神经炎症和ERK/ mapk相关蛋白的表达。结果:IS大鼠神经功能缺损评分升高,梗死体积分数增大,伴有缺血半暗带组织病理学损伤加重。小胶质细胞M1极化增强,同时IL-6和TNF-α上调,而抗炎介质IL-10下调,表明神经炎症反应明显。特别是Western blot结果显示,IS组大鼠缺血半暗区RKIP表达明显低于对照组。通过慢病毒介导实现RKIP过表达后,IS大鼠缺血半暗区小胶质细胞极化方向向M2表型转移。具体表现为iNOS + /Iba1 +双阳性小胶质细胞比例显著降低,而Arg-1 + /Iba1 +双阳性小胶质细胞比例显著升高,神经炎症反应得到缓解。过表达可显著降低缺血半暗区p-ERK1/2和p-p38 MAPK的表达。有趣的是,rmegf激活的ERK提高了缺血半暗区p-ERK1/2和p-p38 MAPK的蛋白水平,而不改变RKIP本身的表达。因此,iNOS + /Iba1 +双阳性小胶质细胞的比例出现反弹,而Arg-1 + /Iba1 +双阳性小胶质细胞的比例下降。最后,功能实验表明,ERK部分逆转了IS大鼠中RKIP过表达所赋予的神经炎症保护。结论:过表达RKIP可能通过抑制ERK/MAPK通路减轻IS大鼠神经炎症损伤,从而改善神经功能。
{"title":"RKIP regulates the ERK/MAPK signaling pathway to improve neuroinflammatory injury in male rats with ischemic stroke","authors":"Rui Mao,&nbsp;Xin Tan,&nbsp;Rong Li,&nbsp;Zhiyong Yang,&nbsp;Hua Liu","doi":"10.1016/j.jstrokecerebrovasdis.2026.108560","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2026.108560","url":null,"abstract":"<div><h3>Background</h3><div>To explore the mechanism by which RAF kinase inhibitory protein (RKIP) alleviates neuroinflammatory damage in male rats with ischemic stroke (IS).</div></div><div><h3>Methods</h3><div>Male rats were subjected to middle cerebral artery occlusion (MCAO) to establish an IS model. Two weeks before MCAO, a single tail-vein injection of lentivirus or an equivalent volume of normal saline was administered to rats. The neurological deficit scores, infarct volume fractions, and pathological changes of the ischemic penumbra were evaluated in the rats. Immunohistochemstry, double-labeled immunofluorescence, ELISA, and Western blot were performed to assess microglial polarization, neuroinflammation and ERK/MAPK-related protein expressions.</div></div><div><h3>Results</h3><div>IS rats exhibited elevated neurological deficit scores and enlarged infarct volume fractions, accompanied by aggravated histopathological damage in the ischemic penumbra. Microglial M1 polarization was enhanced, meanwhile, IL-6 and TNF-α were up-regulated, whereas the anti-inflammatory mediator IL-10 was down-regulated, indicating a pronounced neuroinflammatory response. In particular, Western blot results showed that the ischemic penumbra expression of RKIP in IS rats was markedly lower in IS group than that in Control group. After achieving RKIP overexpression via lentivirus mediation, the polarization direction of microglia in the ischemic penumbra of IS rats shifted toward the M2 phenotype. This was specifically manifested by a significant decrease in the proportion of iNOS⁺/Iba1⁺ double-positive microglia, while the proportion of Arg-1⁺/Iba1⁺ double-positive microglia was significantly increased, and the neuroinflammatory response was alleviated. Moreover, its overexpression significantly reduced the expressions of p-ERK1/2 and p-p38 MAPK in ischemic penumbra. Interestingly, rmEGF-activated ERK elevated the protein levels of p-ERK1/2 and p-p38 MAPK in ischemic penumbra without altering RKIP expression itself. Consequently, the proportion of iNOS⁺/Iba1⁺ double-positive microglia rebounded, while that of Arg-1⁺/Iba1⁺ double-positive microglia decreased . Finally, functional experiments demonstrated that ERK partially reversed the neuroinflammatory protection conferred by RKIP overexpression in IS rats.</div></div><div><h3>Conclusion</h3><div>Overexpression of RKIP may alleviate the neuroinflammatory damage in IS rats by inhibiting ERK/MAPK pathway, thereby improving neurological function.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 3","pages":"Article 108560"},"PeriodicalIF":1.8,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145992973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological contextualization and interpretation of early gastrostomy timing in nontraumatic intracerebral hemorrhage 非外伤性脑出血早期胃造口时机的方法学背景和解释
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2026-01-13 DOI: 10.1016/j.jstrokecerebrovasdis.2026.108558
Andrea Loggini MD MPH MBA , Victor J. Del Brutto MD , Faddi G. Saleh Velez MD , Jonatan Hornik MD , Awni D. Shahait MD , Denise Battaglini MD PhD , Shawn S. Wallery MD , Alejandro Hornik MD , Christos Lazaridis MD , Adnan I. Qureshi MD
{"title":"Methodological contextualization and interpretation of early gastrostomy timing in nontraumatic intracerebral hemorrhage","authors":"Andrea Loggini MD MPH MBA ,&nbsp;Victor J. Del Brutto MD ,&nbsp;Faddi G. Saleh Velez MD ,&nbsp;Jonatan Hornik MD ,&nbsp;Awni D. Shahait MD ,&nbsp;Denise Battaglini MD PhD ,&nbsp;Shawn S. Wallery MD ,&nbsp;Alejandro Hornik MD ,&nbsp;Christos Lazaridis MD ,&nbsp;Adnan I. Qureshi MD","doi":"10.1016/j.jstrokecerebrovasdis.2026.108558","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2026.108558","url":null,"abstract":"","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 3","pages":"Article 108558"},"PeriodicalIF":1.8,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145981132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of perioperative outcome factors after hemicraniectomy confirms age as the prognostic factor in patients with middle cerebral artery infarction: Evidence from real-world data 半脑切除术后围手术期预后因素的评估证实年龄是大脑中动脉梗死患者的预后因素:来自现实世界数据的证据
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2026-01-12 DOI: 10.1016/j.jstrokecerebrovasdis.2026.108557
Regina Isemann MD , Florian Wild MD , Paul Bronzlik MD , Joachim K. Krauss MD , Thomas Stüber MD , Kurt-Wolfram Sühs MD

Background

Malignant middle cerebral artery (MCA) infarction is a serious condition for which hemicraniectomy can improve survival and outcome. However, it remains unclear to what extent other perioperative factors contribute to the outcome.

Methods

This monocentric, retrospective observational study included patients with MCA infarction and subsequent hemicraniectomy. Perioperative parameters were collected from 68 patients between 01/2012 and 12/2020. Logistic regression analysis was performed to establish determinants for the outcome measured by the Modified Rankin Scale (mRS) (dichotomized in mRS 0-3: favorable outcome, mRS 4-6: poor outcome) 12 months after stroke.

Results

Before event, most patients had no impairment (mRS 0, 75 %) or mild impairment (mRS 1-3, 23.5 %). 12 months after stroke, 18 patients (32 %) had favorable outcome (mRS 0-3). In univariable analysis, age (OR[95 %CI]: 1.124[1.045,1.208], p = 0.002) and the pre-existing conditions diabetes (OR[95 %CI]: 10.625[1.279,88.293], p = 0.029) and hypertension (OR[95 %CI]: 3.875[1.159,12.961], p = 0.028) were associated with poor outcome, as were more points of effort for intensive care complex treatment in the Simplified Acute Physiology Score (SAPS) in the first two days after stroke (ORday1[95 %CIday1]: 1.109[1.023,1.203], pday1 = 0.012) (ORday2[95 %CIday2]: 1.209[1.078,1.355], pday2 = 0.001). All other collected periinterventional parameters (i.e. sedation, fever) did not influence the outcome. In multivariable analysis, older age (OR[95 %CI]: 1.107[1.029,1.190], p = 0.006) was found to be an independent predictor of higher mRS (4-6). For age, our ROC analysis showed a cut-off point of 57 years.

Conclusion

Our data provide information about changes in the degree of impairment and its improvement over time beyond the acute phase of stroke. Of all included parameters, age emerged as the most important prognostic factor.
恶性大脑中动脉(MCA)梗死是一种严重的疾病,半脑切除术可以提高生存率和预后。然而,尚不清楚其他围手术期因素对结果的影响程度。方法本研究为单中心、回顾性观察性研究,纳入MCA梗死患者和随后的半脑切除术患者。收集2012年1月至2020年12月期间68例患者的围手术期参数。采用Logistic回归分析确定脑卒中后12个月采用改良兰金量表(mRS)测量结果的决定因素(mRS分为0-3:预后良好,mRS 4-6:预后不良)。结果事件发生前,大多数患者无损伤(mRS 0.75%)或轻度损伤(mRS 1-3, 23.5%)。卒中后12个月,18例(32%)患者预后良好(mRS 0-3)。在单变量分析中,年龄(或1.124[95%可信区间]:[1.045,1.208],p = 0.002)和预先存在的条件下糖尿病(或10.625[95%可信区间]:[1.279,88.293],p = 0.029)和高血压(或3.875[95%可信区间]:[1.159,12.961],p = 0.028)与贫穷有关的结果,更有分的努力简化复杂重症监护治疗的急性生理评分(SAPS)后的头两天行程(ORday1 CIday1 [95%]: 1.109 (1.023, 1.203), pday1 = 0.012) (ORday2 CIday2 [95%]:1.209[1.078,1.355], pday2 = 0.001)。所有其他收集的围手术期参数(如镇静、发热)不影响结果。在多变量分析中,发现年龄较大(OR[95% CI]: 1.107[1.029,1.190], p = 0.006)是较高mRS的独立预测因子(4-6)。对于年龄,我们的ROC分析显示截断点为57岁。结论:我们的数据提供了脑卒中急性期后损伤程度的变化及其改善的相关信息。在所有纳入的参数中,年龄成为最重要的预后因素。
{"title":"Assessment of perioperative outcome factors after hemicraniectomy confirms age as the prognostic factor in patients with middle cerebral artery infarction: Evidence from real-world data","authors":"Regina Isemann MD ,&nbsp;Florian Wild MD ,&nbsp;Paul Bronzlik MD ,&nbsp;Joachim K. Krauss MD ,&nbsp;Thomas Stüber MD ,&nbsp;Kurt-Wolfram Sühs MD","doi":"10.1016/j.jstrokecerebrovasdis.2026.108557","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2026.108557","url":null,"abstract":"<div><h3>Background</h3><div>Malignant middle cerebral artery (MCA) infarction is a serious condition for which hemicraniectomy can improve survival and outcome. However, it remains unclear to what extent other perioperative factors contribute to the outcome.</div></div><div><h3>Methods</h3><div>This monocentric, retrospective observational study included patients with MCA infarction and subsequent hemicraniectomy. Perioperative parameters were collected from 68 patients between 01/2012 and 12/2020. Logistic regression analysis was performed to establish determinants for the outcome measured by the Modified Rankin Scale (mRS) (dichotomized in mRS 0-3: favorable outcome, mRS 4-6: poor outcome) 12 months after stroke.</div></div><div><h3>Results</h3><div>Before event, most patients had no impairment (mRS 0, 75 %) or mild impairment (mRS 1-3, 23.5 %). 12 months after stroke, 18 patients (32 %) had favorable outcome (mRS 0-3). In univariable analysis, age (OR[95 %CI]: 1.124[1.045,1.208], p = 0.002) and the pre-existing conditions diabetes (OR[95 %CI]: 10.625[1.279,88.293], p = 0.029) and hypertension (OR[95 %CI]: 3.875[1.159,12.961], p = 0.028) were associated with poor outcome, as were more points of effort for intensive care complex treatment in the Simplified Acute Physiology Score (SAPS) in the first two days after stroke (OR<sub>day1</sub>[95 %CI<sub>day1</sub>]: 1.109[1.023,1.203], p<sub>day1</sub> = 0.012) (OR<sub>day2</sub>[95 %CI<sub>day2</sub>]: 1.209[1.078,1.355], p<sub>day2</sub> = 0.001). All other collected periinterventional parameters (i.e. sedation, fever) did not influence the outcome. In multivariable analysis, older age (OR[95 %CI]: 1.107[1.029,1.190], p = 0.006) was found to be an independent predictor of higher mRS (4-6). For age, our ROC analysis showed a cut-off point of 57 years.</div></div><div><h3>Conclusion</h3><div>Our data provide information about changes in the degree of impairment and its improvement over time beyond the acute phase of stroke. Of all included parameters, age emerged as the most important prognostic factor.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 3","pages":"Article 108557"},"PeriodicalIF":1.8,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145981130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The association of recurrent stroke and immunoglobulin G4-related arteritis in the central nervous system: a case report 脑卒中复发与中枢神经系统免疫球蛋白g4相关性动脉炎的关系:1例报告
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2026-01-12 DOI: 10.1016/j.jstrokecerebrovasdis.2026.108556
Qi Huang , Hongjian Shen , Pengfei Xing, Yi Jiang, Xiaolong Xu, Qiang Li, Yongwei Zhang

Background

Immunoglobulin G4–related disease (IgG4-RD) is a systemic immune-mediated fibroinflammatory disease. Histopathology is the key to diagnosis. Although aortitis/periaortitis is a phenotype of IgG4-related disease, the relationship between cerebrovascular disease and IgG4-related disease remains unclear.

Methods

We report a 60-year-old man with recurrent stroke induced by IgG4-related arteritis and present the pathological findings of the patient's superficial temporal artery and middle cerebral artery.

Results

Immunohistochemistry demonstrated scattered plasma cells in the intima and adventitia of the superficial temporal artery, with a small number of IgG4-positive cells observed (10–15 cells per high-power field).

Conclusions

Case reports and studies examining the association between IgG4-related neurological arteritis and stroke are limited. Although a definitive link between IgG4-related arteritis (IgG4-RA) and stroke has not been established, IgG4-related arteritis should be considered as an etiology in patients with recurrent idiopathic stroke.
背景免疫球蛋白g4相关疾病(IgG4-RD)是一种全身性免疫介导的纤维炎性疾病。组织病理学是诊断的关键。虽然主动脉炎/动脉周炎是igg4相关疾病的一种表型,但脑血管疾病与igg4相关疾病的关系尚不清楚。方法报告1例60岁男性igg4相关性动脉炎所致复发性脑卒中,并报告患者颞浅动脉和大脑中动脉的病理表现。结果免疫组化结果显示,颞浅动脉内膜和外膜内分散可见浆细胞,少量igg4阳性细胞(高倍视场10 ~ 15个)。结论研究igg4相关性神经动脉炎与脑卒中相关性的病例报告和研究有限。虽然igg4相关动脉炎(IgG4-RA)与卒中之间的明确联系尚未建立,但在复发性特发性卒中患者中,igg4相关动脉炎应被视为一种病因。
{"title":"The association of recurrent stroke and immunoglobulin G4-related arteritis in the central nervous system: a case report","authors":"Qi Huang ,&nbsp;Hongjian Shen ,&nbsp;Pengfei Xing,&nbsp;Yi Jiang,&nbsp;Xiaolong Xu,&nbsp;Qiang Li,&nbsp;Yongwei Zhang","doi":"10.1016/j.jstrokecerebrovasdis.2026.108556","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2026.108556","url":null,"abstract":"<div><h3>Background</h3><div>Immunoglobulin G4–related disease (IgG4-RD) is a systemic immune-mediated fibroinflammatory disease. Histopathology is the key to diagnosis. Although aortitis/periaortitis is a phenotype of IgG4-related disease, the relationship between cerebrovascular disease and IgG4-related disease remains unclear.</div></div><div><h3>Methods</h3><div>We report a 60-year-old man with recurrent stroke induced by IgG4-related arteritis and present the pathological findings of the patient's superficial temporal artery and middle cerebral artery.</div></div><div><h3>Results</h3><div>Immunohistochemistry demonstrated scattered plasma cells in the intima and adventitia of the superficial temporal artery, with a small number of IgG4-positive cells observed (10–15 cells per high-power field).</div></div><div><h3>Conclusions</h3><div>Case reports and studies examining the association between IgG4-related neurological arteritis and stroke are limited. Although a definitive link between IgG4-related arteritis (IgG4-RA) and stroke has not been established, IgG4-related arteritis should be considered as an etiology in patients with recurrent idiopathic stroke.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 3","pages":"Article 108556"},"PeriodicalIF":1.8,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145981131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic syndrome severity and stroke risk: a longitudinal analysis in middle-aged and older chinese adults 代谢综合征严重程度与卒中风险:中国中老年成人的纵向分析。
IF 1.8 4区 医学 Q3 NEUROSCIENCES Pub Date : 2026-01-09 DOI: 10.1016/j.jstrokecerebrovasdis.2026.108553
Wang Rong MD , Zhanlan Zhu MD , Dongji Wang MD , Wenbin Shang MD

Background

Metabolic syndrome (MetS) contributes to cerebrovascular disease in older adults. Traditional binary diagnostic criteria may not fully capture metabolic dysfunction or its impact on stroke risk.

Objective

This study explores the relationship between MetS severity and stroke risk.

Methods

Data were derived from the China Health and Retirement Longitudinal Study (2011–2018). MetS severity was quantified using a validated scoring algorithm, and a cumulative severity score was calculated as the average of MetS scores at waves 1 and 3, weighted by the interval between waves. Cox proportional hazards models evaluated the relationship between baseline MetS severity and stroke events, while logistic regression assessed cumulative score in relation to incident stroke occurring after wave 3. Restricted cubic spline (RCS) functions were applied to explore nonlinear associations. Subgroup and interaction analyses were performed, and sensitivity analyses excluded participants receiving metabolic-related medications or with stroke occurring within two years prior to follow-up.

Results

During a median follow-up of 7 years, 459 stroke cases were documented (7.04%). Each interquartile increase in baseline MetS score was associated with a 33.4% higher stroke risk (HR = 1.334; 95% CI 1.239–1.436). Stroke risk increased significantly across quartiles (P for trend < 0.0001), with the highest quartile exhibiting nearly a threefold greater risk compared with the lowest (HR = 2.923; 95% CI 2.208–3.871). Cumulative MetS score was also positively associated with stroke (OR = 1.034; 95% CI 1.025–1.043), with the highest quartile showing significantly elevated odds (OR = 1.069; 95% CI 1.049–1.092). RCS analyses demonstrated significant nonlinear associations between baseline and cumulative MetS scores and stroke risk in the overall population, whereas linear associations were observed in stratified analyses according to MetS status. Additional analyses assessing changes in MetS score between waves 1 and 3 showed no significant association with stroke risk.

Conclusion

Greater MetS severity is independently associated with increased stroke risk among middle-aged and older Chinese adults. These findings highlight the need for continuous surveillance of MetS severity and timely intervention to mitigate stroke burden in aging populations.
背景:代谢综合征(MetS)与老年人脑血管疾病有关。传统的二元诊断标准可能不能完全捕获代谢功能障碍或其对卒中风险的影响。目的:探讨MetS严重程度与卒中风险的关系。方法:数据来源于中国健康与退休纵向研究(2011-2018)。使用经过验证的评分算法对MetS的严重程度进行量化,并计算累积严重性评分为第1和第3波MetS评分的平均值,并按波之间的间隔加权。Cox比例风险模型评估基线MetS严重程度与卒中事件之间的关系,而逻辑回归评估累积评分与第3波后发生的卒中事件的关系。利用限制三次样条函数(RCS)来研究非线性关联。进行了亚组分析和相互作用分析,敏感性分析排除了接受代谢相关药物治疗或随访前两年内发生中风的参与者。结果:在中位随访7年期间,记录了459例卒中病例(7.04%)。基线met评分每增加四分位数,卒中风险增加33.4% (HR = 1.334;95% CI 1.239-1.436)。卒中风险在四分位数中显著增加(P < 0.0001),最高四分位数的风险比最低四分位数的风险高出近三倍(HR = 2.923;95% CI 2.208-3.871)。累积MetS评分也与卒中呈正相关(OR = 1.034;95% CI 1.025-1.043),最高的四分位数显示显著升高的几率(OR = 1.069;95% CI 1.049-1.092)。RCS分析显示,基线和累积MetS评分与总体人群卒中风险之间存在显著的非线性关联,而根据MetS状态进行分层分析则观察到线性关联。额外的分析评估了第1波和第3波之间MetS评分的变化,显示与卒中风险没有显著关联。结论:在中国中老年人群中,较大的MetS严重程度与卒中风险增加独立相关。这些发现强调了持续监测MetS严重程度和及时干预以减轻老年人群卒中负担的必要性。
{"title":"Metabolic syndrome severity and stroke risk: a longitudinal analysis in middle-aged and older chinese adults","authors":"Wang Rong MD ,&nbsp;Zhanlan Zhu MD ,&nbsp;Dongji Wang MD ,&nbsp;Wenbin Shang MD","doi":"10.1016/j.jstrokecerebrovasdis.2026.108553","DOIUrl":"10.1016/j.jstrokecerebrovasdis.2026.108553","url":null,"abstract":"<div><h3>Background</h3><div>Metabolic syndrome (MetS) contributes to cerebrovascular disease in older adults. Traditional binary diagnostic criteria may not fully capture metabolic dysfunction or its impact on stroke risk.</div></div><div><h3>Objective</h3><div>This study explores the relationship between MetS severity and stroke risk.</div></div><div><h3>Methods</h3><div>Data were derived from the China Health and Retirement Longitudinal Study (2011–2018). MetS severity was quantified using a validated scoring algorithm, and a cumulative severity score was calculated as the average of MetS scores at waves 1 and 3, weighted by the interval between waves. Cox proportional hazards models evaluated the relationship between baseline MetS severity and stroke events, while logistic regression assessed cumulative score in relation to incident stroke occurring after wave 3. Restricted cubic spline (RCS) functions were applied to explore nonlinear associations. Subgroup and interaction analyses were performed, and sensitivity analyses excluded participants receiving metabolic-related medications or with stroke occurring within two years prior to follow-up.</div></div><div><h3>Results</h3><div>During a median follow-up of 7 years, 459 stroke cases were documented (7.04%). Each interquartile increase in baseline MetS score was associated with a 33.4% higher stroke risk (HR = 1.334; 95% CI 1.239–1.436). Stroke risk increased significantly across quartiles (P for trend &lt; 0.0001), with the highest quartile exhibiting nearly a threefold greater risk compared with the lowest (HR = 2.923; 95% CI 2.208–3.871). Cumulative MetS score was also positively associated with stroke (OR = 1.034; 95% CI 1.025–1.043), with the highest quartile showing significantly elevated odds (OR = 1.069; 95% CI 1.049–1.092). RCS analyses demonstrated significant nonlinear associations between baseline and cumulative MetS scores and stroke risk in the overall population, whereas linear associations were observed in stratified analyses according to MetS status. Additional analyses assessing changes in MetS score between waves 1 and 3 showed no significant association with stroke risk.</div></div><div><h3>Conclusion</h3><div>Greater MetS severity is independently associated with increased stroke risk among middle-aged and older Chinese adults. These findings highlight the need for continuous surveillance of MetS severity and timely intervention to mitigate stroke burden in aging populations.</div></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"35 3","pages":"Article 108553"},"PeriodicalIF":1.8,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145954926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Stroke & Cerebrovascular Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1